Vitiligo-like lesions in melanoma treated with interleukin-2: 4 cases
Wolkenstein, P.; Chosidow, O.; Guillaume, J.C.; Wechsler, J.; Avril, M.F.; Revuz, J.
Annales de Dermatologie et de Venereologie 119(11): 907-909
1992
ISSN/ISBN: 0151-9638 PMID: 1301719 Document Number: 392374
Document emailed within 1 workday
Related Documents
Legha, S.S. 1997: Durable complete responses in metastatic melanoma treated with interleukin-2 in combination with interferon alpha and chemotherapy Seminars in Oncology 24(1 Suppl 4: S39-S43Keilholz, U.; Scheibenbogen, C.; Stoelben, E.; Saeger, H.D.; Hunstein, W. 1994: Immunotherapy of metastatic melanoma with interferon-alpha and interleukin-2: pattern of progression in responders and patients with stable disease with or without resection of residual lesions European Journal of Cancer 30a(7): 955-958
Juranic, Z.D.; Stanojevic-Bakic, N.; Zizak, Z.; Babovic, N.; Radovic-Kovacevic, V.; Stanojkovic, T.; Dzodic, R. 2003: Antimelanoma immunity in vitiligo and melanoma patients Neoplasma 50(4): 305-309
Castelli, C.; Sensi, M.; Lupetti, R.; Mortarini, R.; Panceri, P.; Anichini, A.; Parmiani, G. 1994: Expression of interleukin 1 alpha, interleukin 6, and tumor necrosis factor alpha genes in human melanoma clones is associated with that of mutated N-RAS oncogene Cancer Research 54(17): 4785-4790
Day, C.L.; Mihm, M.C.; Sober, A.J.; Fitzpatrick, T.B.; Malt, R.A.; Kopf, A.W.; Lew, R.A.; Harrist, T.J. 1982: Skin lesions suspected to be melanoma should be photographed. Gross morphological features of primary melanoma associated with metastases JAMA 248(9): 1077-1081
Adloff, M.; Jaeck, D.; Arnaud, J.P.; Paris, F.; Baumann, R.; Sontag, D.; Aprosio, N.; Weill-Bousson, M. 1984: Surgical treatment of villous and adenovillous lesions of the duodenum. Analysis of 9 surgically treated cases Chirurgie; Memoires de l'Academie de Chirurgie 110(5): 492-498
Kumon, Y.; Zenke, K.; Ohta, S.; Hatakeyama, T.; Sakaki, S.; Yanagihara, N. 1995: Operative results in fourteen cases of paranasal sinus and anterior cranial fossa lesions surgically treated by an extended transbasal approach No Shinkei Geka. Neurological Surgery 23(10): 889-895
Tarhini, A.A.; Agarwala, S.S. 2005: Interleukin-2 for the treatment of melanoma Current Opinion in Investigational Drugs 6(12): 1234-1239
Philip, P.A.; Flaherty, L. 1997: Treatment of malignant melanoma with interleukin-2 Seminars in Oncology 24(1 Suppl 4: S32-S38
Akyol, M.; Celik, V.Kenan.; Ozcelik, S.; Polat, M.; Marufihah, M.; Atalay, A. 2002: The effects of vitamin E on the skin lipid peroxidation and the clinical improvement in vitiligo patients treated with PUVA European Journal of Dermatology: Ejd 12(1): 24-26
Atkins, M.B. 2000: Interleukin-2 in metastatic melanoma: what is the current role? Cancer Journal from Scientific American 6(Suppl 1): S8-10
Tawade, Y.V.; Parakh, A.P.; Bharatia, P.R.; Gokhale, B.B.; Ranganathan, H.N.; Deshpande, D.R. 1997: Vitiligo : a study of 998 cases attending KEM Hospital in Pune Indian Journal of Dermatology Venereology and Leprology 63(2): 95-98
Ugolotti, U.; Larini, P.; Mandrioli, R.; Miselli, A.; Villani, L.G.; Japichino, G.G.; Azzarone, M. 1991: Recanalization with laser and angioplasty of atherosclerotic lesions of the legs. Personal experience with 31 treated lesions La Radiologia Medica 81(5): 691-694
Bennicelli, J.L.; Elias, J.; Kern, J.; Guerry, D. 1989: Production of interleukin 1 activity by cultured human melanoma cells Cancer Research 49(4): 930-935
de Braud, F.; Biganzoli, L.; Bajetta, E.; Colleoni, M.; Zampino, M.G. 1993: Subcutaneous low-dose interleukin-2 plus alpha interferon in advanced malignant melanoma Tumori 79(3): 187-190
Walos, S.; Szary, J.; Szala, S. 1999: Inhibition of tumor growth by interleukin 10 gene transfer in B16(F10) melanoma cells Acta Biochimica Polonica 46(4): 967-970
García de Galdeano; Boyano, D.; Smith-Zubiaga, I.; Alvarez, A.; Cantón, I.; Cañavate, L. 1998: Involvement of interleukin-6 in the biology and metastatic activity of B16F10 melanoma cells European Cytokine Network 9(2): 187-192
Vidal-Vanaclocha, F.; Amézaga, C.; Asumendi, A.; Kaplanski, G.; Dinarello, C.A. 1994: Interleukin-1 receptor blockade reduces the number and size of murine B16 melanoma hepatic metastases Cancer Research 54(10): 2667-2672
Novik, A.V.; Novik, B.I.; Moiseenko, V.M. 2007: Prognostic significance of DNA ploidy in disseminated malignant skin melanoma and the effectiveness of interleukin-2 (IL-2) treatment Voprosy Onkologii 53(2): 164-169
Dabrowska, A.; Giermasz, A.; Marczak, M.; Gołab, J.; Jakóbisiak, M. 2000: Potentiated antitumor effects of interleukin 12 and matrix metalloproteinase inhibitor batimastat against B16F10 melanoma in mice Anticancer Research 20(1a): 391-394